Montelukast Sandoz 4 (Montelukast)

montelukast 4 mg chewable tablet, 28 · ORAL · PBS code 14526M

STREAMLINED

What it costs

AU$4.09 PBS-determined price per 56 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

• First listed on the PBS: 2024-09-01.
• Repeats: 5.
• PBS program: GE.

Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Asthma

First-line prevention

The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND

Patient must be aged 2 to 5 years inclusive; AND

The condition must be frequent intermittent; or

The condition must be mild persistent; AND

The treatment must be the single preventer agent; AND

The treatment must be an alternative to sodium cromoglycate; or

The treatment must be an alternative to nedocromil sodium.

Sponsor: Sandoz Pty Ltd ABN 60 075 449 553

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.